Gentian Diagnostics ASA
F:6FK
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
G
|
Gentian Diagnostics ASA
F:6FK
|
NO |
|
Dottikon Es Holding AG
F:DTI0
|
CH |
|
Boss Energy Ltd
F:B8Y
|
AU |
|
P
|
PICIC Insurance Ltd
KAR:PIL
|
PK |
|
I
|
Ingenia Communities Group
OTC:INGEF
|
AU |
|
T
|
Tradegate AG Wertpapierhandelsbank
XMUN:T2G
|
DE |
|
G
|
Ghani Value Glass Ltd
KAR:GVGL
|
PK |
|
CI Games SA
F:CI7
|
PL |
Wall St Price Targets
6FK Price Targets Summary
Gentian Diagnostics ASA
According to Wall Street analysts, the average 1-year price target for 6FK is 7.09 EUR with a low forecast of 7.02 EUR and a high forecast of 7.3 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6FK's stock price target?
Price Target
7.09
EUR
According to Wall Street analysts, the average 1-year price target for 6FK is 7.09 EUR with a low forecast of 7.02 EUR and a high forecast of 7.3 EUR.
What is the Revenue forecast for Gentian Diagnostics ASA?
Projected CAGR
15%
Over the last 9 years, the compound annual growth rate for Revenue has been 25%. The projected CAGR for the next 3 years is 15%.
What is the Gross Profit forecast for Gentian Diagnostics ASA?
Projected CAGR
24%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 22%. The projected CAGR for the next 3 years is 24%.
What is the Operating Income forecast for Gentian Diagnostics ASA?
Projected CAGR
31%
The compound annual growth rate for Operating Income over the next 3 years is 31%.
What is the Pre-Tax Income forecast for Gentian Diagnostics ASA?
Projected CAGR
53%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 53%.
What is the Net Income forecast for Gentian Diagnostics ASA?
Projected CAGR
80%
The compound annual growth rate for Net Income over the next 3 years is 80%.
